Publications by Center Staff

2002

Fukumoto H, Cheung BS, Hyman BT and Irizarry MC (2002). ß-secretase protein and activity are increased in the neocortex in alzheimer’s disease. Arch Neurol; 59: 1381-1389.

2002

Swearer JM, Drachman DA, Li L, Kane KJ, Dessureau B and Tabloski P (2002). Screening for dementia in “real world” settings. the cognitive assessment screening test:  cast. The Clinical Neuropsychologist; 16: 128-135.

2002

Shibata N, Hirano A, Hedley-Whyte ET, Cal Canto MC, Nagai R, Uchida K, Horiuchi S, Kawaguchi M, Yamamoto T and Kobayashi M (2002). Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Acta Neuropathol; 104: 171-178.

2002

Swearer JM (2002). Sleep disturbances.  Evidence-Based Dementia:  A Practical Guide to Diagnosis and Treatment. N Qizilbash, L Schneider, H Chui, G Wilcock, P Tariot, H Brodaty and K Kaye (Eds.). Oxford, UK, Blackwell Science Ltd:  711-716.

2002

Pollen DA, Przybyszewski AW, Rubin MA and Foote W (2002). Spatial receptive field organization of macaque v4 neurons. Cerebral Cortex; 12:  601-616.

2002

Augustinack JC, Schneider A, Mandelkow E-M and Hyman BT (200). Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in alzheimer's disease. Acta Neuropathol; 103: 26-35.

2002

Hardy J and Selkoe DJ (2002). The amyloid hypothesis of alzheimer’s disease:  progress and problems on the road to therapeutics. Science; 297:  353-356.

 

2002

Pugh KG and Lipsitz LA (2002). The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging; 23: 421-431.

2002

Drachman DA (200). The treatment of alzheimer’s disease:  where have we been, and where are we going?  Am J Alzheimer’s Dis and Other Dementias; 17: 133-134.

2001

Irizarry MC and Hyman BT (2001). Alzheimer disease therapeutics. J Neuropath Exp Neurol; 60: 923-928.